Purchase 5-Methyl-Ethylone
Discount program, second order - 5%OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 5-Methyl-Ethylone for sale
5-Methyl-Ethylone (5ME), also known as "5-Methylbutylone," is an empathogen, stimulant and psychedelic drug of the amphetamine, phenethylamine, and cathinone chemical classes. There is little data about the pharmacological properties, metabolism, and toxicity of 5-methylethylketone, though it has been sold as a designer drug.
5-Methyl-Ethylone (5ME), also known as 5-Methylbutylone, is a methylamine stimulant and psychotropic substance of the amphetamine, phenethylamine and methcathinone chemical classes that are "similar to Mephedrone."
5-Methyl-Ethylone (5ME) is a synthetic stimulant with psychedelic and empathogenic properties. It is similar in structure to alpha-PVP and Methylone.
5-Methyl-Ethylone is a synthetic drug with stimulant and hallucinogenic properties.
In the United States, 5-methylethylketone is a Schedule I substance under the Federal Controlled Substances Act of 1970. This scheduling includes a narrative that summarizes the important data related to the drug and provides an accurate portrayal of its benefits and harm.
5-methylethylketone is a designer drug that the European Monitoring Centre first identified for Drugs and Drug Addiction in November 2012.
5ME is a series of chemicals containing an amphetamine core and a methylenedioxy-substituted ethyl chain.
5-Methyl-βk-MDEA (5ME, 5-Methyl-Ethylone) is an empathogen and stimulant of the substituted cathinone and amphetamine classes. It is structurally related to βk-MDEA and ethylene. This drug has been sold online as a designer drug.
5-Methyl-Ethylone (Ecstasy) is a new drug that has been gaining popularity since it was first seen on the streets of Europe. 5-METHYL-ETHYLONE (5ME) is also known as Methylone, bk-MDEA or βk-MDMA. It is chemically related to Methylone (bk-MDMA); its effects are supposedly similar, if not slightly more entactogenic and psychedelic than Methylone. Different from other drugs available worldwide, 5me contains:
• An ester bond within its structure is similar to the 2C series.
• Making it more efficient to metabolize into the physiologically active molecule.
• Therefore having an easier onset than most substances.
5-Methyl-Ethylone is an empathogen, stimulant and psychedelic drug of the amphetamine, phenethylamine, and cathinone chemical classes. The recommended doses for single use are between 50-250 mg orally (oral insufflation is not recommended due to low bioavailability) and 100 mg intranasally.
5-Methyl-Ethylone (5-Methylethylone), originally known as Ethyloin. This RC is a psychostimulant and empathogen, effectively resulting in energy alongside mental stimulation in some users. Similarly to MDMA and MDA, this RC produces hallucinations and euphoria by releasing serotonin and dopamine into the body - leading to increased pleasure during the use.
5-Methyl Ethylone (5-ME), pharmacologically known as 5-Methylethylone, is an empathogen and stimulant which acts as a Norepinephrine - Dopamine reuptake inhibitor (NDRI).
5-Methyl-Ethylone is a derivative of the cathinone class. It has stimulating, empathogenic and hallucinogenic properties.
5-Methyl-Ethylone (5-MeOE) is a designer drug with psychedelic effects. It's even more potent and hallucinogenic than 2C-B and Ethylone.
5-Methyl-Ethylone (also known as 5ME or 5methylethylone) is a stimulant and supplement used for recreational and medical purposes. It has many of the same effects as cocaine, including euphoria, enhanced alertness and energy, increased dopamine levels in the brain, and increased heart rate and breathing rate.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
500g $1080
1kg $1590
out of stock
100g $510
100g $550
500g $1199
1kg $1890
out of stock
500g $1080
100mg $840
500g $1300